MARIZYME Chief Medical Officer Steven Brooks receives $317K in 2021
MARIZYME reports 2021 executive compensation
By ExecPay News
Published: November 10, 2022
MARIZYME reported fiscal year 2021 executive compensation information on November 10, 2022.
In 2021, eight MARIZYME executives received on average a compensation package of $188K, a 2% increase compared to previous year.
Average pay of disclosed executives at MARIZYME
Steven Brooks, Chief Medical Officer, received $317K in total. 95% of Brooks' compensation, or $300K, was in salary. Brooks also received $17K in option awards.
Catherine Pachuk, Chief Scientific Officer, received a compensation package of $299K, which increased by 31% compared to previous year. 100% of the compensation package, or $299K, was in salary.
Amy Chandler, Former Executive Vice President of Regulatory Affairs and Quality Management Systems, earned $213K in 2021.
James Sapirstein, Chief Executive Officer, received $203K in 2021.
Neil J. Campbell, Chief Executive Officer, earned $194K in 2021, a 38% increase compared to previous year.
Roger Schaller, former Executive Vice President of Commercial Operations, received $173K in 2021.
David Barthel, Chief Executive Officer, earned $58K in 2021.
Vithalbhai Dhaduk, Chief Executive Officer, received $48K in 2021.
Related executives
David Barthel
MARIZYME
Chief Executive Officer
Neil Campbell
MARIZYME
Chief Executive Officer
Vithalbhai Dhaduk
MARIZYME
Chief Executive Officer
Catherine Pachuk
MARIZYME
Chief Scientific Officer
Steven Brooks
MARIZYME
Chief Medical Officer
James Sapirstein
MARIZYME
Chief Executive Officer
Amy Chandler
MARIZYME
Former Executive Vice President of Regulatory Affairs and Quality Management Systems
Roger Schaller
MARIZYME
former Executive Vice President of Commercial Operations
You may also like
Source: SEC filing on November 10, 2022.